Disturbed sleep is a prominent feature of fibromyalgia symptomatology and has been proposed as one of the core symptoms that should be systematically assessed in clinical trials for the treatment ...

"Establishing that fibromyalgia is an autoimmune disorder will transform how we view the condition and should pave the way ...

may not be generalizable to men Investigation of single-treatment approach Incorporate combination therapies Many patients benefit from combination of pharmacological and nonpharmacological ...

Recognizing these underlying principles is essential in devising holistic treatment approaches that address the multifaceted nature of fibromyalgia and empower individuals to regain control over ...

Both MS and fibromyalgia may cause chronic pain and fatigue, they are very distinct conditions. A correct diagnosis is important to ensure proper treatment. Multiple sclerosis (MS) is an ...

Durability of therapeutic response to milnacipran treatment for fibromyalgia. Results of a randomized, double-blind, monotherapy 6-month extension study. Pain Med. 11 , 180–194 (2010).

Chronic pain remains a significant challenge around the world, while traditional treatments like opioids and physical therapy ...

The following is a summary of “Feasibility of attention-based virtual reality interventions in fibromyalgia syndrome: comparing systems, virtual environments and activities,” published in the January ...

TNX-102 SL is a non-opioid, centrally-acting analgesic administered at bedtime for the treatment of fibromyalgia. The Food and Drug Administration (FDA) has accepted the New Drug Application (NDA ...

Fast Track designation has the goal of bringing new treatments to patients sooner. In granting Fast Track, FDA recognized fibromyalgia as a "serious condition", which shows the recognition that ...